US Stock MarketDetailed Quotes

APGNW APEXIGEN INC C/WTS 29/07/27 (TO PUR COM)

Watchlist
  • 0.026
  • 0.0000.00%
Close Aug 24 09:30 ET
0Market Cap0.00P/E (TTM)

About APEXIGEN INC C/WTS 29/07/27 (TO PUR COM) Company

Apexigen Inc is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, with an emphasis on new immuno-oncology agents designed to harness the patient’s immune system to combat and eradicate cancer.. The company’s pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in clinical development, and also includes several preclinical stage immune-oncology programs.

Company Profile

SymbolAPGNW
Company NameAPEXIGEN INC C/WTS 29/07/27 (TO PUR COM)
CEODr. Xiaodong Yang, M.D.
MarketNASDAQ
Employees20
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.apexigen.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Xiaodong Yang, M.D.
  • Chief Executive Officer and Director
  • 1.16M
  • Francis W. Sarena
  • President and Chief Operating Officer
  • 1.50M
  • Dr. Frank J. Hsu, M.D.
  • Chief Medical Officer
  • 1.40M
  • William Duke, Jr
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Amy Wong
  • Senior Vice President, Finance and Operations
  • --
  • Meenu Chhabra Karson
  • Chairman of the Board
  • 212.06K
  • Herbert C. Cross
  • Independent Director
  • 236.20K
  • Dr. Gordon Ringold,PhD
  • Independent Director
  • 234.71K
  • Scott A. Smith
  • Independent Director
  • 231.96K
  • Dr. Samuel P. Wertheimer, PhD
  • Independent Director
  • 199.34K
  • Dr. Dan Zabrowski
  • Independent Director
  • 206.76K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg